Cancer doctors call for more training in palliative care and delivery of ‚bad news‘

Baltimore, MD, USA (May 28, 2020) — Oncologists who practice and teach at the Johns Hopkins Kimmel Cancer Center are calling on medical oncology training programs to invest substantially more time educating physicians about palliative care and how to talk to patients about „bad news.“

In a commentary published on April 9, 2020, in the Journal of Clinical Oncology, the physicians noted studies showing that cancer doctors deliver bad news to patients an average of 35 times a month. „However, few have training in how best to do so,“ says Ramy Sedhom, M.D., a medical oncology fellow at the Johns Hopkins University School of Medicine and lead author.

According to the researchers, oncology fellows — those who have embarked on lengthy post-doctoral training programs specializing in cancer care — report getting more coaching on how to perform technical procedures such as bone marrow biopsies than how to conduct a meeting with patients and families facing difficult or limited choices in care and disease outcomes. At the same time, Sedhom says, research suggests that how doctors frame difficult conversations can influence and direct patient preferences for treatment or palliative care.

As advances in treatment have increased in number and complexity in recent years, many oncologists have moved from practicing general medical oncology to focusing on just one or two cancers, says Thomas J. Smith, M.D., professor of oncology and director of palliative medicine at the Johns Hopkins University School of Medicine.

„As a consequence,“ he says, „the abilities of these doctors to predict patient outcomes becomes even more complicated and highlights the need for palliative care training.“

Smith, Sedhom and colleagues previously surveyed accredited oncology training programs in the United States, finding none that offered a combined or integrated medical oncology and hospice/palliative care medicine program. Seventy-three institutions, including Johns Hopkins Medicine, offer the training in separate programs.

Smith and Sedhom say their commentary finds that training in the science of communication can help oncologists effectively address patient emotions and in turn, help patients and their families make more informed decisions about treatment choices.


Johns Hopkins Medicine, 28.05.2020 (tB).

MEDICAL NEWS

Novel biomarker discovery could lead to early diagnosis for deadly…
Why do more women have Alzheimer’s than men? It’s not…
New research highlights potential cardiovascular risk of novel anti-osteoporotic drug
Asymptomatic COVID-19 patients also contaminate the environment
At height of COVID-19, nurses and doctors reported high levels…

SCHMERZ PAINCARE

DBfK: Besondere Rolle für Pflegeexpert/innen Schmerz – nicht nur in…
Vagus-Stimulation: Neuartige Strom-Impulse lindern Schmerz
Aktuelle Aspekte der Anwendung von Cannabinoiden in Schmerz- und Palliativmedizin:…
Deutsche Gesellschaft für Neurologie (DGN): Ingwerextrakt hilft nicht zur Prophylaxe…
„LONTS“ – Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen: Dt.…

DIABETES

Continuous glucose monitoring reduces hypoglycemia in older adults with type…
COVID-19 may trigger new diabetes, experts warn
„Körperstolz“: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Robert Koch-Institut: Fast Food, Bio-Lebensmittel, Energydrinks – Journal of Health…
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Eisenmangel/-anämie bei Tumorpatienten: Frühzeitige Diagnose und Therapie sind entscheidend
Gentest zur Vorbeugung von Chemotherapie-Nebenwirkungen. Alte Substanzen vor neuen Herausforderungen
Fortbildung für Pflegende zum „OncoCoach“
Hochauflösende 3D-Ansicht des Tumorinneren bei Brustkrebs mit optoakustischer Mesoskopie
Angst vor COVID-19 verzögert Diagnose und Therapie bei Krebspatienten

MULTIPLE SKLEROSE

Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei aktiver…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Case series: Teriflunomide therapy in COVID-19 patients with MS
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…
Projekt VAFES: Expertenteam entwickelt Diagnosesystem für Parkinson-Patienten